These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 36344198)
1. New understanding of multidrug efflux and permeation in antibiotic resistance, persistence, and heteroresistance. Manrique PD; López CA; Gnanakaran S; Rybenkov VV; Zgurskaya HI Ann N Y Acad Sci; 2023 Jan; 1519(1):46-62. PubMed ID: 36344198 [TBL] [Abstract][Full Text] [Related]
2. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria. Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI mBio; 2017 Oct; 8(5):. PubMed ID: 29089426 [TBL] [Abstract][Full Text] [Related]
3. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors. Zgurskaya HI; Walker JK; Parks JM; Rybenkov VV Acc Chem Res; 2021 Feb; 54(4):930-939. PubMed ID: 33539084 [TBL] [Abstract][Full Text] [Related]
4. Permeability barriers of Gram-negative pathogens. Zgurskaya HI; Rybenkov VV Ann N Y Acad Sci; 2020 Jan; 1459(1):5-18. PubMed ID: 31165502 [TBL] [Abstract][Full Text] [Related]
5. Trans-envelope multidrug efflux pumps of Gram-negative bacteria and their synergism with the outer membrane barrier. Zgurskaya HI; Rybenkov VV; Krishnamoorthy G; Leus IV Res Microbiol; 2018; 169(7-8):351-356. PubMed ID: 29454787 [TBL] [Abstract][Full Text] [Related]
6. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections. Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF mBio; 2020 Sep; 11(5):. PubMed ID: 32934086 [TBL] [Abstract][Full Text] [Related]
7. Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use. Lomovskaya O; Bostian KA Biochem Pharmacol; 2006 Mar; 71(7):910-8. PubMed ID: 16427026 [TBL] [Abstract][Full Text] [Related]
8. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Blair JM; Richmond GE; Piddock LJ Future Microbiol; 2014; 9(10):1165-77. PubMed ID: 25405886 [TBL] [Abstract][Full Text] [Related]
9. Functional Diversity of Gram-Negative Permeability Barriers Reflected in Antibacterial Activities and Intracellular Accumulation of Antibiotics. Leus IV; Adamiak J; Chandar B; Bonifay V; Zhao S; Walker SS; Squadroni B; Balibar CJ; Kinarivala N; Standke LC; Voss HU; Tan DS; Rybenkov VV; Zgurskaya HI Antimicrob Agents Chemother; 2023 Feb; 67(2):e0137722. PubMed ID: 36715507 [TBL] [Abstract][Full Text] [Related]
10. Nonlethal Molecular Nanomachines Potentiate Antibiotic Activity Against Gram-Negative Bacteria by Increasing Cell Permeability and Attenuating Efflux. Santos AL; Liu D; van Venrooy A; Beckham JL; Oliver A; Tegos GP; Tour JM ACS Nano; 2024 Jan; 18(4):3023-3042. PubMed ID: 38241477 [TBL] [Abstract][Full Text] [Related]
11. The role of efflux pumps ın antıbıotıc resıstance of gram negatıve rods. Başaran SN; Öksüz L Arch Microbiol; 2023 Apr; 205(5):192. PubMed ID: 37060362 [TBL] [Abstract][Full Text] [Related]
12. Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline. Wang Y; Su J; Zhou Z; Yang J; Liu W; Zhang Y; Zhang P; Guo T; Li G Microbiol Spectr; 2023 Jun; 11(3):e0470222. PubMed ID: 37070985 [TBL] [Abstract][Full Text] [Related]
13. Modeling the Kinetics of the Permeation of Antibacterial Agents into Growing Bacteria and Its Interplay with Efflux. Nichols WW Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717042 [TBL] [Abstract][Full Text] [Related]
14. Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens? Domalaon R; Idowu T; Zhanel GG; Schweizer F Clin Microbiol Rev; 2018 Apr; 31(2):. PubMed ID: 29540434 [TBL] [Abstract][Full Text] [Related]
15. Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective. Alibert S; N'gompaza Diarra J; Hernandez J; Stutzmann A; Fouad M; Boyer G; Pagès JM Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):301-309. PubMed ID: 27764576 [TBL] [Abstract][Full Text] [Related]
16. Rationalizing the permeation of polar antibiotics into Gram-negative bacteria. Scorciapino MA; Acosta-Gutierrez S; Benkerrou D; D'Agostino T; Malloci G; Samanta S; Bodrenko I; Ceccarelli M J Phys Condens Matter; 2017 Mar; 29(11):113001. PubMed ID: 28155846 [TBL] [Abstract][Full Text] [Related]
17. The development of efflux pump inhibitors to treat Gram-negative infections. Blanco P; Sanz-García F; Hernando-Amado S; Martínez JL; Alcalde-Rico M Expert Opin Drug Discov; 2018 Oct; 13(10):919-931. PubMed ID: 30198793 [TBL] [Abstract][Full Text] [Related]
18. Bacterial resistance to antibiotics: active efflux and reduced uptake. Kumar A; Schweizer HP Adv Drug Deliv Rev; 2005 Jul; 57(10):1486-513. PubMed ID: 15939505 [TBL] [Abstract][Full Text] [Related]